Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 10;6(3):100458.
doi: 10.1016/j.xhgg.2025.100458. Epub 2025 May 22.

Multidisciplinary stakeholder-informed identification of key characteristics for implementation of workplace genetic testing

Affiliations

Multidisciplinary stakeholder-informed identification of key characteristics for implementation of workplace genetic testing

Elizabeth Charnysh et al. HGG Adv. .

Abstract

Workplace genetic testing (wGT) is an evolving model for genetic testing where employees are offered consumer genetic testing through employer-sponsored wellness programs. However, the potential harms, benefits, and key characteristics for best implementation practices for wGT have yet to be defined. To address this issue, we conducted a three-round modified Delphi process, including multiple rounds of survey and a virtual deliberative workshop, with purposely chosen wGT stakeholders (employees, employers, ethical, legal, and social implications [ELSI] professionals, genetic testing industry representatives, and healthcare professionals) to share their perspectives. From the modified Delphi process, we identified 12 key characteristics for the implementation of wGT that were perceived to increase the potential for benefit while reducing the risk of potential harms. Most participants agreed that privacy/security, voluntariness, transparency, understanding and education, anti-discrimination, employee control, and evidence-based testing measures were both important (>90%) and necessary (>75%) for the implementation of wGT. However, some participants also expressed a lack of confidence in the likelihood of achieving these characteristics in wGT programs. Overall, stakeholders expressed qualified support for wGT at the conclusion of the modified Delphi process. Their perspectives on the topic varied over the course of the process and were at least partially contingent on whether the aforementioned 12 key characteristics were met. These findings help inform the establishment of a normative framework for wGT assessment.

Keywords: Delphi; ELSI; genetic testing; wellness programs; workplace genetic testing.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests The authors declare no competing interests.

Figures

Figure 1
Figure 1
Key characteristics of workplace genetic testing (wGT) and their importance, necessity, and likelihood of being achieved as perceived by participants (n = 30) Importance (x), likelihood of being achieved (y), with shapes of symbols (legend) denoting the percentage of participants who indicated the key characteristic was “necessary” for wGT to be offered. Values plotted on the x/y axes represent mean of Likert-scale scores for each characteristic.

References

    1. Halbisen A.L., Lu C.Y. Trends in Availability of Genetic Tests in the United States, 2012-2022. J. Pers. Med. 2023;13 doi: 10.3390/jpm13040638. - DOI - PMC - PubMed
    1. Dusic E.J., Theoryn T., Wang C., Swisher E.M., Bowen D.J., EDGE Study Team Barriers, interventions, and recommendations: Improving the genetic testing landscape. Front. Digit. Health. 2022;4 doi: 10.3389/fdgth.2022.961128. - DOI - PMC - PubMed
    1. Oh B. Direct-to-consumer genetic testing: advantages and pitfalls. Genomics Inform. 2019;17 doi: 10.5808/GI.2019.17.3.e33. - DOI - PMC - PubMed
    1. Helgason A., Stefánsson K. The past, present, and future of direct-to-consumer genetic tests. Dialogues Clin. Neurosci. 2010;12:61–68. doi: 10.31887/DCNS.2010.12.1/ahelgason. - DOI - PMC - PubMed
    1. Kirby H.G., Rehm H.L., Hull L.E. An Environmental Scan of Consumer-Initiated Germline Genetic Testing for Health Risks. Mayo Clin. Proc. 2023;98:1529–1543. doi: 10.1016/j.mayocp.2023.04.008. - DOI - PMC - PubMed